Marinus Pharmaceuticals | MRNS - Loan Capital

Marinus Pharmaceuticals reported $71.02M in Loan Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Loan Capital Change
ALKERMES ALKS:US USD 290.27M 634K
Amgen AMGN:US USD 37.35B 193M
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 1.8M
Eisai 4523:JP JPY 84.92B 8M
Enanta Pharmaceuticals ENTA:US USD 1.42M 0
Esperion Therapeutics ESPR:US USD 259.9M 412K
Intercept Pharmaceuticals ICPT:US USD 223.1M 248K
Marinus Pharmaceuticals MRNS:US USD 71.02M 238K
Ptc Therapeutics PTCT:US USD 1.28B 294.53M
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M
YTE INCY:US USD 30.08M 393K